Early Aldosterone Blockade in Acute Myocardial Infarction-Reference-Cited by-同舟云学术

Early Aldosterone Blockade in Acute Myocardial Infarction

Published:2016-04 Issue:16 Volume:67 Page:1917-1927
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Beygui Farzin,Cayla Guillaume,Roule Vincent,Roubille François,Delarche Nicolas,Silvain Johanne,Van Belle Eric,Belle Loic,Galinier Michel,Motreff Pascal,Cornillet Luc,Collet Jean-Philippe,Furber Alain,Goldstein Patrick,Ecollan Patrick,Legallois Damien,Lebon Alain,Rousseau Hélène,Machecourt Jacques,Zannad Faiez,Vicaut Eric,Montalescot Gilles

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference24 articles.

1. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators;Pitt;N Engl J Med,1999

2. Eplerenone in patients with systolic heart failure and mild symptoms;Zannad;N Engl J Med,2011

3. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction;Pitt;N Engl J Med,2003

4. Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study;Montalescot;Eur Heart J,2014

5. High plasma aldosterone levels on admission are associated with death in patients presenting with acute ST-elevation myocardial infarction;Beygui;Circulation,2006

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological and Device-Based Intervention for Preventing Heart Failure After Acute Myocardial Infarction　― A Clinical Review ―;Circulation Journal;2024-09-13

2. Mineralocorticoid Receptor Blocker Prevents Mineralocorticoid Receptor–Mediated Inflammation by Modulating Transcriptional Activity of Mineralocorticoid Receptor–p65–Signal Transducer and Activator of Transcription 3 Complex;Journal of the American Heart Association;2024-09-09

3. Design and rationale of the CLEAR SYNERGY (OASIS 9) trial: A 2x2 factorial randomized controlled trial of colchicine versus placebo and spironolactone vs placebo in patients with myocardial infarction;American Heart Journal;2024-09

4. Aldosterone Effect on Cardiac Structure and Function;Current Cardiology Reviews;2024-07

5. The Efficacy of Acupuncture Therapy in the Management of Dyspnea and Other Symptoms Associated with Heart Failure: A Consolidated Review of Trial Data;Cells Tissues Organs;2024-05-31